An experimental cancer drug had a 100% success rate : NPR
WEBJun 7, 2022 · The new treatment is categorized as immunotherapy. A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental...
Cancer-fighting antibodies inject chemo directly into tumor cells ...
WEBJun 2, 2024 · New research on two different antibody drug conjugates, presented Sunday at the American Society of Clinical Oncology (ASCO) conference in Chicago, found that the treatments helped patients with...
FDA approves groundbreaking treatment for advanced melanoma - NBC News
WEBFeb 16, 2024 · The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated.
New cancer treatment may reawaken the immune system - MIT News
WEBOct 19, 2021 · MIT researchers have now discovered a new way to jump-start the immune system to attack tumors, which they hope could allow immunotherapy to be used against more types of cancer.
A newly approved ‘living drug’ could save more cancer patients’ …
WEBAug 22, 2024 · Tumor-infiltrating lymphocyte, or TIL, therapy is the first T cell treatment for solid tumors. It fights melanoma and maybe other cancers too.
Lifileucel First Cellular Therapy Approved for Cancer
WEBMar 5, 2024 · In an event more than three decades in the making, the Food and Drug Administration (FDA) has approved lifileucel (Amtagvi), the first treatment for cancer that uses immune cells called tumor-infiltrating lymphocytes, or TILs.
‘Dramatic’ inroads against aggressive brain cancer - Harvard Gazette
WEBMar 14, 2024 · A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment. In a paper published Wednesday in The New England Journal of Medicine, researchers from Mass General Cancer …
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
WEBJun 7, 2022 · Drugs that block HER2 have been stunningly effective in treating breast cancers that are almost entirely populated with the protein, turning HER2-positive breast cancers from those with some of...
Stanford Medicine delivers first FDA-approved cell-based therapy …
WEBMay 6, 2024 · The new treatment, which uses immune cells harvested from a patient’s tumor called tumor-infiltrating lymphocytes, exploits the body’s own natural cancer-fighting ability.
Cancer Currents: An NCI Cancer Research Blog - NCI
WEBAug 29, 2024 · People with advanced endometrial cancer now have new FDA-approved treatment options: pembrolizumab and durvalumab, paired with chemotherapy, for tumors with a genetic change called mismatch repair deficiency.
Skip to content